Release of endogenous opioids during a chronic IBD model suppresses the excitability of colonic DRG neurons

Neurogastroenterology and Motility

Volumn 25, Issue 1, 2013, Pages

  Valdez Morales, E ^a,b   Guerrero Alba, R ^a   Ochoa Cortes, F ^a   Benson, J ^a   Spreadbury, I ^a   Hurlbut, D ^a   Miranda Morales, M ^c   Lomax, A E ^a   Vanner, S ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b INSTITUTO POTOSINO DE INVESTIGACIÓN CIENTÍFICA Y TECNOLÓGICA   (Mexico)

^c INSTITUTO DE NEUROBIOLOGÍA   (Mexico)

Author keywords

Dorsal root ganglia; DSS colitis; Endogenous opioids; IBD

Indexed keywords

BETA ENDORPHIN; DEXTRAN SULFATE; ENDORPHIN; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; FAST BLUE; NALOXONE; VOLTAGE GATED POTASSIUM CHANNEL;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CD4+ T LYMPHOCYTE; COLITIS; CONTROLLED STUDY; ENTERITIS; FLOW CYTOMETRY; IMMUNOREACTIVITY; MOUSE; NERVE CELL EXCITABILITY; NONHUMAN; PATCH CLAMP; POTASSIUM CURRENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL GANGLION; VOLTAGE CLAMP;

ACTION POTENTIALS; ANIMALS; BETA-ENDORPHIN; CELL SEPARATION; CHRONIC DISEASE; COLON; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GANGLIA, SPINAL; IMMUNOHISTOCHEMISTRY; INFLAMMATORY BOWEL DISEASES; MICE; MICE, INBRED C57BL; PATCH-CLAMP TECHNIQUES;

EID: 84871667242     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/nmo.12008     Document Type: Article

References (32)

1. Ibeakanma C, Vanner S. TNFalpha is a key mediator of the pronociceptive effects of mucosal supernatant from human ulcerative colitis on colonic DRG neurons. Gut 2010; 59: 612-21.
2. Farthing MJ, Lennard-Jones JE. Sensibility of the rectum to distension and the anorectal distension reflex in ulcerative colitis. Gut 1978; 19: 64-9.
3. Bernstein CN, Niazi N, Robert M et al. Rectal afferent function in patients with inflammatory and functional intestinal disorders. Pain 1996; 66: 151-61.
4. Verma-Gandhu M, Verdu EF, Bercik P et al. Visceral pain perception is determined by the duration of colitis and associated neuropeptide expression in the mouse. Gut 2007; 56: 358-64.
5. Busch-Dienstfertig M, Stein C. Opioid receptors and opioid peptide-producing leukocytes in inflammatory pain--basic and therapeutic aspects. Brain Behav Immun 2010; 24: 683-94.
6. Philippe D, Dubuquoy L, Groux H et al. Anti-inflammatory properties of the mu opioid receptor support its use in the treatment of colon inflammation. J Clin Invest 2003; 111: 1329-38.
7. Philippe D, Chakass D, Thuru X et al. Mu opioid receptor expression is increased in inflammatory bowel diseases: implications for homeostatic intestinal inflammation. Gut 2006; 55: 815-23.
8. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998; 115: 182-205.
9. Present DH, Rutgeerts P, Targan S et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med 1999; 340: 1398-405.
10. Sartor RB. Cytokines in intestinal inflammation: pathophysiological and clinical considerations. Gastroenterology 1994; 106: 533-9.
11. Verma-Gandhu M, Bercik P, Motomura Y et al. CD4+ T-cell modulation of visceral nociception in mice. Gastroenterology 2006; 130: 1721-8.
12. Moore BA, Stewart TM, Hill C, Vanner SJ. TNBS ileitis evokes hyperexcitability and changes in ionic membrane properties of nociceptive DRG neurons. Am J Physiol Gastrointest Liver Physiol 2002; 282: G1045-51.
13. Stewart T, Beyak MJ, Vanner S. Ileitis modulates potassium and sodium currents in guinea pig dorsal root ganglia sensory neurons. J Physiol 2003; 3: 797-807.
14. Beyak MJ, Vanner S. Inflammation-induced hyperexcitability of nociceptive gastrointestinal DRG neurones: the role of voltage-gated ion channels. Neurogastroenterol Motil 2005; 17: 175-86.
15. Gold MS, Shuster MJ, Levine JD. Characterization of six voltage-gated K+ currents in adult rat sensory neurons. J Neurophysiol 1996; 75: 2629-46.
16. Yoshimura N, De Groat WC. Increased excitability of afferent neurons innervating rat urinary bladder after chronic bladder inflammation. J Neurosci 1999; 19: 4644-53.
17. Annahazi A, Dabek M, Gecse K et al. Proteinase-activated receptor-4 evoked colorectal analgesia in mice: an endogenously activated feed-back loop in visceral inflammatory pain. Neurogastroenterol Motil 2012; 24: 76-85, e13.
18. Auge C, Balz-Hara D, Steinhoff M, Vergnolle N, Cenac N. Protease-activated receptor-4 (PAR 4): a role as inhibitor of visceral pain and hypersensitivity. Neurogastroenterol Motil 2009; 21: 1189-e107.
19. Karanjia R, Spreadbury I, Bautista-Cruz F, Tsang ME, Vanner S. Activation of protease-activated receptor-4 inhibits the intrinsic excitability of colonic dorsal root ganglia neurons. Neurogastroenterol Motil 2009; 21: 1218-21.
20. Miller RJ, Jung H, Bhangoo SK, White FA. Cytokine and chemokine regulation of sensory neuron function. Handb Exp Pharmacol 2009; 194: 417-49.
21. Wright KL, Duncan M, Sharkey KA. Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation. Br J Pharmacol 2008; 153: 263-70.
22. Boue J, Blanpied C, Djata-Cabral M, Pelletier L, Vergnolle N, Dietrich G. Immune conditions associated with CD4+ T effector-induced opioid release and analgesia. Pain 2012; 153: 485-93.
23. Stein C, Clark JD, Oh U et al. Peripheral mechanisms of pain and analgesia. Brain Res Rev 2009; 60: 90-113.
24. Chen JH, Wei SZ, Chen J et al. Sensory denervation reduces visceral hypersensitivity in adult rats exposed to chronic unpredictable stress: evidences of neurogenic inflammation. Dig Dis Sci 2009; 54: 1884-91.
25. Landau AM, Yashpal K, Cahill CM, St LM, Ribeiro-da-Silva A, Henry JL. Sensory neuron and substance P involvement in symptoms of a zymosan-induced rat model of acute bowel inflammation. Neuroscience 2007; 145: 699-707.
26. Pan XQ, Gonzalez JA, Chang S, Chacko S, Wein AJ, Malykhina AP. Experimental colitis triggers the release of substance P and calcitonin gene-related peptide in the urinary bladder via TRPV1 signaling pathways. Exp Neurol 2010; 225: 262-73.
27. Hughes PA, Harrington AM, Castro J et al. Sensory neuro-immune interactions differ between irritable bowel syndrome subtypes. Gut 2012; doi:10.1136/gutjnl-2011-301856.
28. Connor JA, Stevens CF. Prediction of repetitive firing behaviour from voltage clamp data on an isolated neurone soma. J Physiol 1971; 213: 31-53.
29. Zollner C, Mousa SA, Fischer O et al. Chronic morphine use does not induce peripheral tolerance in a rat model of inflammatory pain. J Clin Invest 2008; 118: 1065-73.
30. Tsai RY, Tai YH, Tzeng JI, Cherng CH, Yeh CC, Wong CS. Ultra-low dose naloxone restores the antinociceptive effect of morphine in pertussis toxin-treated rats by reversing the coupling of mu-opioid receptors from Gs-protein to coupling to Gi-protein. Neuroscience 2009; 164: 435-43.
31. Sengupta JN, Snider A, Su X, Gebhart GF. Effects of kappa opioids in the inflamed rat colon. Pain 1999; 3: 175-85.
32. Engel MA, Becker C, Reeh PW, Neurath MF. Role of sensory neurons in colitis: increasing evidence for a neuroimmune link in the gut. Inflamm Bowel Dis 2011; 17: 1030-3.